Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.11 (
AMPK
)
12,425
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MEKA
is an acidic 33-kilodalton phosphoprotein found in the retina and pineal gland. It is of interest because it forms a cytoplasmic heterotrimer with the beta gamma-complex of GTP-binding regulatory proteins (G proteins). Accordingly,
MEKA
may play a role in signal transduction.
MEKA
is phosphorylated on Ser73 by
cAMP-dependent protein kinase
. In the present report,
MEKA
was studied using an antiserum (Anti-32) against MEKA65-96, which can be used to estimate total
MEKA
and the phosphorylation state of
MEKA
. It was confirmed that
MEKA
is rapidly phosphorylated by adrenergic stimulation of pineal glands in organ culture. In addition, total (dephosphorylated)
MEKA
was observed to increase after a 6-h treatment with norepinephrine or (Bu)2 cAMP, an effect which was dependent upon new protein synthesis. In in vivo studies, it was found that the total amount of
MEKA
and
MEKA
phosphorylation were increased at night in the dark, a time when the pineal gland is adrenergically stimulated. The high level of phosphorylation was rapidly reduced when animals were exposed to light, which blocks neural stimulation of the gland. This report provides the first in vivo evidence that
MEKA
phosphorylation is under physiological control, and that
MEKA
synthesis is controlled by an adrenergic----cAMP mechanism which requires protein synthesis.
...
PMID:Photoneural control of the synthesis and phosphorylation of pineal MEKA (phosducin). 165 28